Form 4: Danaher EVP Exercises, Sells Shares in Planned Transaction
Insider Transaction Report
Danaher Executive Vice President Gregory M. Milosevich exercised stock options and subsequently sold an equal number of common shares in a pre-planned transaction.
Summary
- Gregory M. Milosevich, Executive Vice President of Danaher Corp (DHR), executed a series of transactions on February 19, 2026.
- He exercised employee stock options to acquire 1,320 shares of common stock at an exercise price of $58.59 per share.
- Concurrently, he sold 1,320 shares of Danaher common stock at a price of $208.011 per share.
- These transactions resulted in a net zero change in his direct beneficial ownership of common stock for the day, maintaining 5,099 shares, while fully liquidating his remaining 1,320 employee stock options.
- The options had a grant date of February 24, 2016, were exercisable over five years, and were set to expire on February 24, 2026.
- The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine executive compensation event, reflecting the monetization of vested stock options. The significant spread between exercise and sale price indicates strong past stock performance for Danaher, which is a positive signal.
Positives
- Executive Milosevich realized a significant gain by exercising options at $58.59 and selling at $208.011, indicating a substantial increase in Danaher's stock value since the option grant date of February 24, 2016.
Negatives
- The sale of shares by an Executive Vice President, even if routine, represents a reduction in the executive's direct equity exposure to the company.
Risks
- NA
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly option exercises followed by sales of an equal number of shares, are common events in executive compensation structures. These transactions often reflect executives monetizing vested equity rather than a change in their fundamental view of the company's prospects, especially when executed under a Rule 10b5-1 trading plan, indicating a pre-arranged and routine event.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The transaction provides transparency into executive compensation and insider holdings, which can influence investor sentiment regarding management's alignment with shareholder interests.
- Employees: Highlights the value of equity compensation programs within the company, demonstrating the potential for wealth creation through stock options.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 02/24/2016 | Grant date of employee stock options, with exercisability over five years. |
| 02/19/2026 | Date of option exercise and subsequent sale of common stock. |
| 02/20/2026 | Signature date of the reporting person's attorney-in-fact on the Form 4. |
| 02/24/2026 | Expiration date of the employee stock options. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event involving the exercise of stock options and a subsequent sale of shares. It does not provide new fundamental information about Danaher's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The transaction reflects the monetization of vested equity and is part of a pre-planned trading strategy, thus having a neutral impact on the company's investment thesis.
Keywords
Danaher, DHR, SEC Form 4, Insider Trading, Stock Options, Executive Compensation, Share Sale, Milosevich, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.